In spite of the drug's toxicity, cyclosporine A (CsA) is largely used in several diseases, including dermatological pathologies, with beneficial results. In dermatology cyclosporin-A reduces the severity of psoriasis symptoms, Bechet's disease, pyoderma gangrenosum, blistering disorders, aftous stomatitis, lichen planus, atopic dermatitis, alopecia and allergic contact dermatitis.
KauvarA.B. and StillerM.J.. 1994. Cyclosporin in dermatology: pharmacology and clinical use. Int. J. Dermatol.33:1023.
2.
FradinM.S.EllisC.N. and VoorheesJ.J.. 1990. Management of patient and side effects during cyclosporin therapy for cutaneous disorders. J. Am. Acad. Dermatol.23:1265.
3.
HewittC.W. and BlackK.S.. 1996. Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants. Transpl. Proc.28: 922.
4.
PatamM.A.TranH.S.LullR.ChrzanowskiF.A.Jr.BlackK.S. and HewittC.W.. 2000. Site-specific immunosuppression: mechanisms of cellular immunosuppression that are operative at local and systemic levels. J. Burn Care Rehabil. 21:10.
5.
BousemaM.T.TankB.HeuleF.. 1990. Placebo-controlled study of psoriasis patient treated topically with a 10% cyclosporin gel. J. Am. Acad. Dermatol.22:126.
6.
De ProstY.BodemerC. and TeillacD.. 1989. Randomized double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis. Acta Derm. Venereol.144 (S): 136.
7.
EisenD. and EllisC.N.. 1990. Topical cyclosporin for oral mucosal disorders. J. Am. Acad. Dermatol.23:1259.
8.
FrancesC.BoisnicS.EtienneS. and SzpirglasH.. 1988. Effect of the local application of cyclosporin A on chronic erosive lichen planus of the oral cavity. Dermatological177: 194.
9.
EisenD.EllisC.N. and VoorheesJ.J.. 1990. Topical cyclosporin for oral bullous disorders. J. Am. Acad. Dermatol.323:936.
10.
HermannR.C.TaylorR.S.EllisC.N.. 1988. Topical cyclosporin A for psoriasis: in vitro skin penetration and clinical study. Skin Pharmacol. 1:246.
11.
GilharA.PillarT. and EtzioniA.. 1989. Topical cyclosporin A in alopecia areata. Acta Derm. Venereol.69: 252.
12.
TranH.S.MalliD.ChrzanowskiF.A.PucM.M.MatthewsM.S. and HewittC.W.. 1999. Site-specific immunosuppression using a new formulation of topical cyclosporin A with polyethylene glycol-8 glyceryl caprylate/caprate. J. Surg. Res.83:136.
13.
De RieM.A.MeinardiM.H. and BosJ. A.1991. Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis. Acta derm Venereol. 71: 452.
14.
WatkinsP.B.1990. The role of cytochromes -450 in cyclosporin metabolism. J. Am. Acad. Dermatol.23:1275.
15.
KunzendorfU.BrockmollerJ.JochimsenF.RootsI. and OffermanG.. 1989. Immunosuppressive properties of cyclosporin metabolites. Lancet18:734.
16.
MrowietzU.1999. Macrolide immunosuppressants. Eur. J. Dermatol.9:346.
17.
BornhovdE.C.SchullerE.BieberT. and WollenberA.. 2000. Immunosuppressive macrolides and their use in dermatology. Hautarzt51:646.
18.
NasrI.S.2000. Topical tacrolimus in dermatology. Clin. Exp. Dermatol.25:250.
19.
MollisonK.W.FeyT.A.GauvinD.M.. 1998. Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases. Curr. Pharm. Des.4:367.
20.
TranH.S.MalliD.ChrzanowskiF.A.PucM.MatthewsM.S. and HewittC.W.. 1999. Site-specific immunosuppression using a new formulation of topical cyclosporin A with polyethylene glycol-8 glyceryl caprylate/caprate. J. Surg. Res.83:136.
21.
WongR.L.WinslowC.M. and CooperK.D.. 1993. The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol. Today14: 69.
22.
DuncanJ.I.WakeelR.A.WinfieldA.J. and OrmerodA.D.1993. Thomson. Immunomodulation of psoriasis with a topical cyclosporin A formulation. Acta Derm. Venereol.73:84.
23.
ThomsonA.W.NalesnikM.A.RiloH.R.WooJ.CarrollP.B. and Van ThielD.H.. 1993. ICAM 1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity15:215.
24.
ThomsonA.W.SewellH.F. and AldridgeR.D.. 1987. Topical cyclosporin and immunologically-mediated skin disorders. Lancet1(8543):1212.
25.
GriffithsC.E.PowelesA.V.BakerB.S. and FryL.. 1987. Topical cyclosporin and psoriasis. Lancet1(8536): 806.
26.
GilharA.WintersteinG. and GolanD.T.. 1988. Topical cyclosporin in psoriasis. J. Am. Acad. Dermatol.18:378.
27.
PowlesA.V.BakerB.S.McFaddenJ.RutmanA.J.GriffithsC.E. and FryL.. 1988. Intralesional injection of cyclosporin in psoriasis. Lancet1(8584):537.
28.
ChoiH.K.FlynnG.L. and AmidonG.L.. 1995. Percutaneous absorption and dermal delivery of cyclosporin A. J. Pharm. Sci.84:581.
29.
LimK.K.SuW.P.SchroeterA.L.SabersC.J.AbrahamR.T. and PittelkowM.R.. 1996. Cyclosporin in the treatment of dermatologic disease: an update. Mayo Clin. Proc.71: 1182.
30.
ErgunT.GurbuzO.YurdakulS.HamuryudanV.BekirogluN. and YaziciH.. 1997. Topical cyclosporin-A for treatment of oral ulcers of Behcet's syndrome. Int. J. Dermatol.36:720.
31.
TheissenU.LugerT.A. and SchwarzT.. 1996. Successful topical administration of cyclosporin A in pyoderma gangraenosum. Hautarzt47:132.
32.
MrowietzU. and ChristophersE.. 1991. Clearing of pyoderma gangraenosum by intralesional cyclosporin A. Br. J. Dermatol.125:499.
33.
JitsukawaK.RingJ.WeyerU.KimmigW. and RadloffH.. 1992. Topical cyclosporin in chronic benign familial pemphigus (Hailey-Hailey disease). J. Am. Acad. Dermatol.27:625.
34.
AzanaJ.M.de MisaR.F.BoixedaJ.P. and LedoA.. 1993. Topical cyclosporin for cicatricial pemphigoid. J. Am. Acad. Dermatol.28:134.
35.
GooptuC. and StaughtonR.C.D.. 1998. Use of topical cyclosporin in oral pemphigus. J. Am. Acad. Dermatol.38:860.
36.
EisenD.GriffithsC.E.M.EllisC.N.NickoloffB.J. and VoorheesJ.J.. 1990. Cyclosporin wash for oral lichen planus. Lancet335:535.
37.
HoV.C. and ConklinR.J.. 1991. Effect of topical cyclosporin rinse on oral lichen planus. N. Engl. J. Med.325:435.
38.
VouteA.B.E.SchultenE.A.J.M.LangendijkP.N.J.NieboerC. and van der WaalI.. 1994. Cyclosporin A in an adhesive base for treatment of recalcitrant oral lichen planus. Oral Surg. Oral Med. Oral Pathol. 78:437.
39.
EpsteinJ.B. and TrueloveE.L.. 1996. Topicalcyclosporin in a bioadhesive for treatment of oral lichenoid mucosal reactions. Oral Surg. Oral Med. Oral Pathol. 82:532.
40.
SiegP.von DomarusH.von ZitzewitzV.IvenH. and FarberL.. 1995. Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial. Br. J. Dermatol.132:790.
41.
de ProstY.BodemerC. and TeillacD.. 1989. Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis. Acta Derm. Venereol.144:136.
42.
GianniL.M. and SulliM.M.. 2001. Topical tacrolimus in the treatment of atopic dermatitis. Ann. Pharmacother.35:943.
43.
BekerskyI.FitzsimmonsW.TanaseA.MaherR.M.HodoshE. and LawrenceI.. 2001. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J. Am. Acad. Dermatol.44:17.
44.
RongiolettiF.GuarreraM.TostiA.GuerraL. and PigattoP.. 1992. Topical cyclosporin A fails to improve alopecia areata: a double blind study. J. Dermatol. Treat.3:13.
45.
MaurerM.HandjiskiB. and PausR.. 1997. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am. J. Pathol.159:1433.
46.
SuberC.ItinP.BuchnerS. and MaibachH.I.. 1992. Effect of a new topical cyclosporin formulation on human allergic contact dermatitis. Contact Dermatitis26:116.
